Taminco (TAM) vs. Praxair (PX) Head-To-Head Contrast

Praxair (NYSE: PX) and Taminco (NYSE:TAM) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership.

Analyst Recommendations

This is a summary of current ratings and target prices for Praxair and Taminco, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Praxair 2 6 7 0 2.33
Taminco 0 0 0 0 N/A

Praxair currently has a consensus target price of $155.00, suggesting a potential upside of 3.61%. Given Praxair’s higher possible upside, equities analysts plainly believe Praxair is more favorable than Taminco.

Earnings & Valuation

This table compares Praxair and Taminco’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Praxair $10.53 billion 4.07 $1.50 billion $5.62 26.62
Taminco N/A N/A N/A $0.66 39.39

Praxair has higher revenue and earnings than Taminco. Praxair is trading at a lower price-to-earnings ratio than Taminco, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Praxair and Taminco’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Praxair 14.56% 27.13% 8.34%
Taminco N/A N/A N/A

Insider & Institutional Ownership

86.4% of Praxair shares are held by institutional investors. 0.2% of Praxair shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Dividends

Praxair pays an annual dividend of $3.15 per share and has a dividend yield of 2.1%. Taminco does not pay a dividend. Praxair pays out 56.0% of its earnings in the form of a dividend. Praxair has increased its dividend for 12 consecutive years.

Summary

Praxair beats Taminco on 11 of the 12 factors compared between the two stocks.

About Praxair

Praxair, Inc. is an industrial gas company. The Company’s operations are organized into five segments, four of which have been determined on a geographic basis of segmentation: North America, Europe, South America and Asia. In addition, it operates its surface technologies business through its subsidiary, Praxair Surface Technologies, Inc., which represents the fifth segment. Its operations consist of two product lines: industrial gases and surface technologies. Its industrial gases product line centers on the manufacturing and distribution of atmospheric gases (oxygen, nitrogen, argon, rare gases) and process gases (carbon dioxide, helium, hydrogen, electronic gases, specialty gases). It also designs, engineers and builds equipment that produces industrial gases primarily for internal use. Its Surface Technologies segment, operated through Praxair Surface Technologies, Inc., supplies wear-resistant and high-temperature corrosion-resistant metallic and ceramic coatings and powders.

About Taminco

Taminco Corp is a producer of alkylamines and alkylamine derivatives. The Company’s products are used by its customers in the manufacturing of everyday products primarily for the agriculture, water treatment, personal and home care, animal nutrition and oil and gas end-markets. It operates in 19 countries with seven production facilities and, as of December 31, 2012, had an installed production capacity of 1,272 thousand tons. The Company has three business segments: Functional Amines, Specialty Amines, and Crop Protection. In March 2014, the Company announced that it completed the acquisition of the formic acid business of Kemira Oyj. Its main shareholder is Eastman Chemical Company.

Receive News & Ratings for Praxair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Praxair and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply